Roberto Murialdo

1.3k total citations
32 papers, 381 citations indexed

About

Roberto Murialdo is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Roberto Murialdo has authored 32 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Cancer Research and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Roberto Murialdo's work include Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (6 papers) and HER2/EGFR in Cancer Research (5 papers). Roberto Murialdo is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (6 papers) and HER2/EGFR in Cancer Research (5 papers). Roberto Murialdo collaborates with scholars based in Italy, United States and Netherlands. Roberto Murialdo's co-authors include Alberto Ballestrero, Francesco Boccardo, Giuseppe Schettini, A. Rubagotti, Pamela Guglielmini, Emanuele Romairone, Stefano Scabini, Alessio Signori, Fiammetta Monacelli and Chiara Giannotti and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Roberto Murialdo

29 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Murialdo Italy 11 168 106 80 72 68 32 381
Pasquale Fiduccia Italy 13 180 1.1× 41 0.4× 158 2.0× 110 1.5× 108 1.6× 38 600
Sameer Rastogi India 12 167 1.0× 52 0.5× 215 2.7× 38 0.5× 18 0.3× 115 461
Celaletdin Camcı Türkiye 11 154 0.9× 23 0.2× 97 1.2× 27 0.4× 46 0.7× 31 352
Toshinori Sueda Japan 8 207 1.2× 25 0.2× 116 1.4× 53 0.7× 28 0.4× 63 384
Elena Zafarana Italy 10 121 0.7× 23 0.2× 53 0.7× 124 1.7× 96 1.4× 17 347
Ya‐Wen Ho Taiwan 10 106 0.6× 27 0.3× 54 0.7× 108 1.5× 60 0.9× 15 361
Yueli Tian China 10 130 0.8× 17 0.2× 40 0.5× 82 1.1× 39 0.6× 27 371
Faisal Shahjehan United States 10 264 1.6× 92 0.9× 83 1.0× 69 1.0× 11 0.2× 26 370
Hiroo Makimoto Japan 13 90 0.5× 22 0.2× 42 0.5× 49 0.7× 52 0.8× 32 346

Countries citing papers authored by Roberto Murialdo

Since Specialization
Citations

This map shows the geographic impact of Roberto Murialdo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Murialdo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Murialdo more than expected).

Fields of papers citing papers by Roberto Murialdo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Murialdo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Murialdo. The network helps show where Roberto Murialdo may publish in the future.

Co-authorship network of co-authors of Roberto Murialdo

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Murialdo. A scholar is included among the top collaborators of Roberto Murialdo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Murialdo. Roberto Murialdo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fucà, Giovanni, Alessandra Raimondi, Michele Prisciandaro, et al.. (2022). Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study. The Oncologist. 27(1). e29–e36. 5 indexed citations
2.
Giannotti, Chiara, Andrea Massobrio, Luca Carmisciano, et al.. (2022). Effect of Geriatric Comanagement in Older Patients Undergoing Surgery for Gastrointestinal Cancer: A Retrospective, Before-and-After Study. Journal of the American Medical Directors Association. 23(11). 1868.e9–1868.e16. 6 indexed citations
3.
Borea, Roberto, Gabriella Cirmena, Lorenzo Ferrando, et al.. (2022). Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study. Journal of Translational Medicine. 20(1). 230–230.
4.
Raimondi, Alessandra, Giovanni Fucà, Alberto Giovanni Leone, et al.. (2021). Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. ESMO Open. 6(5). 100246–100246. 10 indexed citations
5.
Tini, Giacomo, Pietro Ameri, Giulia Buzzatti, et al.. (2021). Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer. Frontiers in Cardiovascular Medicine. 8. 654728–654728. 7 indexed citations
6.
Ferrando, Lorenzo, Gabriella Cirmena, Anna Garuti, et al.. (2020). Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma. PLoS ONE. 15(2). e0226595–e0226595. 18 indexed citations
7.
Bossi, Paolo, Mario Airoldi, Maria Antonietta Aloe Spiriti, et al.. (2020). A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches. Expert Opinion on Drug Safety. 19(2). 187–204. 5 indexed citations
8.
Giannotti, Chiara, Gabriele Zoppoli, Lorenzo Ferrando, et al.. (2019). Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters. Journal of Geriatric Oncology. 11(4). 610–616. 5 indexed citations
9.
Giannotti, Chiara, Alessio Signori, Alberto Ballestrero, et al.. (2019). Frailty assessment in elective gastrointestinal oncogeriatric surgery: Predictors of one-year mortality and functional status. Journal of Geriatric Oncology. 10(5). 716–723. 36 indexed citations
10.
Isnaldi, Edoardo, Anna Garuti, Gabriella Cirmena, et al.. (2019). Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer. Journal of Translational Medicine. 17(1). 137–137. 18 indexed citations
11.
12.
Sarocchi, Matteo, Eleonora Arboscello, G Ghigliotti, et al.. (2018). Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction. Chemotherapy. 63(6). 315–320. 8 indexed citations
13.
Zoppoli, Gabriele, Anna Garuti, Gabriella Cirmena, et al.. (2017). Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases. Journal of Translational Medicine. 15(1). 91–91. 19 indexed citations
14.
Altieri, Paola, Roberto Murialdo, Chiara Barisione, et al.. (2017). 5‐fluorouracil causes endothelial cell senescence: potential protective role of glucagon‐like peptide 1. British Journal of Pharmacology. 174(21). 3713–3726. 54 indexed citations
15.
Fornaro, Rosario, et al.. (2015). Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case. Oncology Letters. 10(5). 3103–3106.
16.
Murialdo, Roberto, Monica Gallo, Gabriele Zoppoli, et al.. (2014). Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes.. PubMed. 100(2). 128–35. 2 indexed citations
17.
Miglietta, Loredana, Fortunato Morabito, Nicoletta Provinciali, et al.. (2013). A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: Extension and analysis of a previously reported cohort of patients. European Journal of Surgical Oncology. 39(10). 1046–1052. 21 indexed citations
18.
Murialdo, Roberto, G Pastorino, Manlio Mencoboni, et al.. (2011). Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial. Cancer Chemotherapy and Pharmacology. 68(4). 1009–1016. 3 indexed citations
19.
Murialdo, Roberto, et al.. (2005). Leiomyosarcoma of the broad ligament: a case report and review of literature. International Journal of Gynecological Cancer. 15(6). 1226–1229. 9 indexed citations
20.
Boccardo, Francesco, et al.. (2003). Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. European Journal of Cancer. 40(1). 84–89. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pasquale Fiduccia Breakdown of academic impact, for papers by Sameer Rastogi Breakdown of academic impact, for papers by Celaletdin Camcı Breakdown of academic impact, for papers by Toshinori Sueda Breakdown of academic impact, for papers by Elena Zafarana Breakdown of academic impact, for papers by Ya‐Wen Ho Breakdown of academic impact, for papers by Yueli Tian Breakdown of academic impact, for papers by Faisal Shahjehan Breakdown of academic impact, for papers by Hiroo Makimoto
Rankless by CCL
2026